Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Shenzhen YHLO Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Market Capitalization	8,471	9,010	12,993	11,142	13,993	-
Market Cap Growth	-33.33%	-30.65%	16.62%	-20.38%	-	-
Enterprise Value	8,687	9,226	12,949	10,739	13,697	-
Last Close Price	14.85	15.80	22.58	18.95	23.48	-
PE Ratio	28.02	29.88	36.60	11.01	68.34	-
Forward PE	13.14	16.84	27.31	17.99	34.64	-
PS Ratio	4.25	4.48	6.33	2.80	11.88	-
PB Ratio	3.26	3.34	5.13	4.56	9.24	-
P/TBV Ratio	3.44	3.51	5.49	5.06	9.84	-
P/FCF Ratio	-	-	-	10.95	-	-
P/OCF Ratio	-	17.00	-	7.04	53.90	-
EV/Sales Ratio	4.36	4.59	6.31	2.70	11.63	-
EV/EBITDA Ratio	17.74	14.59	32.56	8.32	44.16	-
EV/EBIT Ratio	28.25	23.60	60.07	9.37	64.96	-
EV/FCF Ratio	-	-	-	10.55	-	-
Debt / Equity Ratio	0.34	0.34	0.22	0.19	0.15	0.41
Debt / EBITDA Ratio	1.43	1.41	1.36	0.37	0.75	0.95
Debt / FCF Ratio	-	-	-	0.47	-	3.40
Asset Turnover	0.49	0.49	0.51	1.25	0.68	0.83
Inventory Turnover	1.07	1.07	1.58	4.15	1.60	1.53
Quick Ratio	1.18	1.02	1.39	1.20	1.51	0.88
Current Ratio	2.12	1.90	2.20	1.63	2.30	1.53
Return on Equity (ROE)	8.55%	10.40%	11.22%	51.59%	17.89%	30.99%
Return on Assets (ROA)	5.66%	5.94%	3.36%	22.55%	7.61%	13.71%
Return on Capital (ROIC)	6.81%	7.29%	4.48%	30.70%	9.32%	16.95%
Return on Capital Employed (ROCE)	11.00%	11.60%	7.30%	42.80%	13.00%	32.80%
Earnings Yield	3.56%	3.35%	2.73%	9.08%	1.46%	-
FCF Yield	-	-0.70%	-5.66%	9.13%	-0.81%	-
Dividend Yield	1.83%	-	1.21%	2.38%	1.22%	-
Payout Ratio	-	56.06%	79.58%	16.70%	5.32%	17.21%
Buyback Yield / Dilution	0.60%	0.64%	-0.70%	-5.53%	-6.03%	-1.26%
Total Shareholder Return	2.43%	0.64%	0.51%	-3.16%	-4.81%	-1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.